MSCs: delivery routes and engraftment, cell‐targeting strategies, and immune modulation
Mesenchymal stem cells (MSCs) are currently being widely investigated both in the lab and
in clinical trials for multiple disease states. The differentiation, trophic, and …
in clinical trials for multiple disease states. The differentiation, trophic, and …
Cytokine-induced killer cells promote antitumor immunity
J Jiang, C Wu, B Lu - Journal of translational medicine, 2013 - Springer
The number of immune cells, especially dendritic cells and cytotoxic tumor infiltrating
lymphocytes (TIL), particularly Th1 cells, CD8 T cells, and NK cells is associated with …
lymphocytes (TIL), particularly Th1 cells, CD8 T cells, and NK cells is associated with …
Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
Background Since most glioblastomas express both wild-type EGFR and EGFRvIII as well
as HER2/neu, they are excellent targets for activated T cells (ATC) armed with bispecific …
as HER2/neu, they are excellent targets for activated T cells (ATC) armed with bispecific …
hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function
W Jiang, C Zhang, Z Tian, J Zhang - Gene Therapy, 2013 - nature.com
Natural killer (NK) cells are characterized by an efficient antitumor activity, and this activity
has been exploited as the basis of cancer immunotherapy strategies. Interferon-α (IFN-α) is …
has been exploited as the basis of cancer immunotherapy strategies. Interferon-α (IFN-α) is …
Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis
Q Liu, Y Wang, H Wang, Y Liu, T Liu… - Journal of cancer research …, 2013 - Springer
Purpose The goal of this study was to provide an experimental basis for the clinical
application of cell immunotherapy on RB in combination with chemotherapy treatment and to …
application of cell immunotherapy on RB in combination with chemotherapy treatment and to …
Engineering antiphagocytic biomimetic drug carriers
Drug-delivery carriers have the potential to not only treat but also diagnose many diseases;
however, they still lack the complexity of natural-particulate systems. Cell-based therapies …
however, they still lack the complexity of natural-particulate systems. Cell-based therapies …
[HTML][HTML] Cytotoxicity of cytokine‑induced killer cells targeted by a bispecific antibody to gastric cancer cells
L Zhang, Y Hou, J Zhang, J Hu… - Oncology …, 2013 - spandidos-publications.com
The aim of the present study was to investigate the cytotoxic activity of cytokine‑induced
killer (CIK) cells targeted by an epidermal growth factor receptor (EGFR)/CD3 bispecific …
killer (CIK) cells targeted by an epidermal growth factor receptor (EGFR)/CD3 bispecific …
[PDF][PDF] Yingying Liu, Tao Liu & Patricia Elena Kunda
Q Liu, Y Wang, H Wang - researchgate.net
Purpose The goal of this study was to provide an experimental basis for the clinical
application of cell immunotherapy on RB in combination with chemotherapy treatment and to …
application of cell immunotherapy on RB in combination with chemotherapy treatment and to …